Phase 2A Pilot C3 Trial of Recurrent/Refractory Metastatic Advanced Pancreatic Cancer

NCT06030622 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

25

Enrollment

OTHER

Sponsor class

Conditions

Pancreatic Cancer Metastatic

Interventions

DRUG: Gemcitabine and C3 (Metformin, Simvastatin, and Digoxin)
DRUG: C3 (Metformin, Simvastatin, and Digoxin) only

Sponsor

State University of New York - Downstate Medical Center